Experiences of DPYD Testing
22/02/2022
Genomic Medicine Service Alliance want to engage with cancer patients who started chemotherapy treatment since November 2020 to listen to your experience of DPYD testing.
DPD testing identifies patients at higher risk of an adverse reaction to the most used chemotherapy treatments. The two most used chemotherapy treatments are either 5-FU (5-fluorouracil) or capecitabine, so if you started chemotherapy treatment after November 2020, then you will have been DYPD tested, as part of your consent to treatment.
Testing helps to identify patients who can be treated more safely with a lower drug dose and is routine practice.
If you received treatment before November 2020 then you are not DPYD tested.
They would love to hear from you so if you would like to share your thoughts and opinions, please contact the NHS North West Genomic Medicine Service Alliance by email in the first instance, to Barbara.coleman@mft.nhs.uk by Friday 11th March 2022.
Recent
Mersey Care Young Carers Strategy Event
Are you a Young Carer? Mersey Care’s Young Carer Consultation events taking place on Tuesday 30th August at Liverpool One Odeon, 9am-1pm and Wednesday 31st August at Warrington Odeon, 9am-1pm. The events will provide a free fun-filled morning allowing our Young Carers to help shape Mersey Care’s...
St Helens Pharmaceutical Needs Assessment 2022-2025 Consultation
You are invited to take part in the St Helens Pharmaceutical Needs Assessment (PNA) 2022-2025 consultation. Community pharmacies are one of the most frequented health care settings in England and play an important role in community health. A PNA is a document which records the assessment of the...
Find Our Facebook Page
Get in touch
Tell us your views about local health and social care services:
Telephone: 0300 111 0007
Email: info@healthwatchsthelens.co.uk
Twitter: @HWStHelens
Click here to sign up for our e newsletter
